Goldman Sachs tips Cochlear shares as a buy

The Cochlear Limited (ASX: COH) share price is up around 260% in 5 years.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Limited (ASX: COH) share price is up around 260% over just the past 5 years from $62.70 to $220.10 today, which goes to show how investing is not rocket science.

Generally, if you buy-to-hold high-quality companies that are likely to grow their free cash flow and dividends over the long term you're likely to generate decent returns.

Warren Buffett for example has made an $85 billion fortune just by buying to hold 'blue chip' type businesses that boast pricing power and some kind of moat or competitive advantage. One recent example being Apple Inc.

If Buffett were Australian and running his SMSF I expect one business he'd also like the look of is hearing device manufacturer Cochlear.

As a market leading business with a competitive advantage via its patented technology it boasts a decent long-term profit growth outlook. 

On June 10 the analysts at Goldman Sachs took a look at the business and slapped a buy rating and $209 12-month share price target on it. That is based on it selling for 26.1x the next 12 months' EV/ EBITDA, which is high but in line with levels the business has traded at historically.

As Goldmans notes the business is a: "Market leader in an attractive space. COH commands a leading share (c.58%) in a structural growth market which is characterized by attractive demographics, relatively favourable pricing, substantial penetration upside and high barriers to entry."

Generally you won't find many companies on the S&P/ ASX200 (ASX: XJO) that boast these kinds of qualities and even though the stock is trading at $220 today and above Goldman's "12 month share price target" it should be on investors' watch lists to own in my opinion. 

Other leading healthcare businesses in Australia include CSL Limited (ASX: CSL) and ResMed Inc. (ASX: RMD). Or as a more speculative alternative you could consider researching Nanosonics Ltd (ASX: NAN) or Pro Medicus Limited (ASX: PME).

Tom Richardson owns shares of Apple, Cochlear Ltd., CSL Ltd., Pro Medicus Ltd., and ResMed Inc.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Apple. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd and has the following options: short January 2020 $155 calls on Apple, long January 2020 $150 calls on Apple, short January 2020 $155 calls on Apple, and long January 2020 $150 calls on Apple. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and Pro Medicus Ltd. The Motley Fool Australia has recommended Apple, Cochlear Ltd., and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »